Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
Drug discovery and development through the commercialization of chemoproteomics, fractionation and mining, purine-binding, mechanism of action determination, and toxicity screening.
Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.
Developing treatments in oncology. Includes overview of disease targets, technology, clinical trials, partnering opportunities and contacts for careers in Cambridge, Massachusetts.
Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.
Business /
Biotechnology_and_Pharmaceuticals /
Pharmaceuticals /
Research_and_Development
|